Company Filing History:
Years Active: 2000
Title: Sean Cunningham: Innovator in Oral Morphine Formulation
Introduction
Sean Cunningham is a notable inventor based in Athlone, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of oral medications. His innovative approach has led to the development of a unique oral morphine multiparticulate formulation.
Latest Patents
Cunningham holds a patent for an oral morphine multiparticulate formulation designed for once-daily administration. This formulation comprises sustained release particles, each containing a core of water-soluble morphine and an osmotic agent. The core is coated with a rate-controlling polymer made of ammonio methacrylate copolymers. This design aims to achieve therapeutically effective plasma levels of morphine over at least 24 hours, providing a reliable solution for patients in need of pain management.
Career Highlights
Sean Cunningham is associated with Elan Corporation, Plc, where he has been instrumental in advancing pharmaceutical innovations. His work focuses on improving patient outcomes through effective drug delivery systems. His dedication to research and development has positioned him as a key player in the industry.
Collaborations
Cunningham collaborates with talented professionals in his field, including Paul Stark and Jagathesan Moodley. These partnerships enhance the innovative processes within his work environment, fostering a culture of creativity and excellence.
Conclusion
Sean Cunningham's contributions to the pharmaceutical industry, particularly through his patent for an oral morphine multiparticulate formulation, highlight his commitment to improving patient care. His work continues to influence the development of effective medication delivery systems.